Have We Revealed the Achilles' Heel of Brigatinib? Implications on Clinical Practice.

Loong, Herbert H; Li, Molly S C; Tang, Gordon C H; Lau, Yat-Ming

Loong, Herbert H; Li, Molly S C; Tang, Gordon C H; Lau, Yat-Ming.

Afiliação

Loong HH; Department of Clinical Oncology, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China; State Key Laboratory in Translational Oncology, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China. Electronic address: h_loong@clo.cuhk.edu.hk.
Li MSC; Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR, China.
Tang GCH; Department of Clinical Oncology, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China; State Key Laboratory in Translational Oncology, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China.
Lau YM; Department of Clinical Oncology, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China; State Key Laboratory in Translational Oncology, The Chinese University of Hong Kong, New Territories, Hong Kong SAR, China.

J Thorac Oncol ; 15(7): 1100-1102, 2020 07.

Article em En | MEDLINE | ID: mdl-32593441

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Neoplasias Pulmonares; Humanos; Compostos Organofosforados; Pirimidinas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google